Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada
08. März 2021 02:00 ET
|
Amryt Pharma plc
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in Canada DUBLIN, Ireland, and Boston MA, March 8, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage...
Amryt to Announce Q4 and FY 2020 Results on Thursday March 4, 2021
24. Februar 2021 02:00 ET
|
Amryt Pharma plc
Amryt to Announce Q4 and FY 2020 Results on Thursday March 4, 2021 DUBLIN, Ireland, and Boston MA, February 24, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage biopharmaceutical...
Amryt and Medison Pharma Sign Multi-Regional Distribution Agreements in Canada and Israel
04. Februar 2021 02:00 ET
|
Amryt Pharma plc
Amryt and Medison Pharma Sign Multi-Regional Distribution Agreements in Canada and Israel DUBLIN, Ireland, and Boston MA, February 4, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage...
Amryt Receives Reimbursement Approval from NICE for Myalepta® (metreleptin) in England and Wales
20. Januar 2021 02:00 ET
|
Amryt Pharma plc
Amryt Receives Reimbursement Approval from NICE for Myalepta® (metreleptin) in England and Wales DUBLIN, Ireland, and Boston MA, January 20, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global,...
Amryt Granted Orphan Drug Designation by the FDA for AP103
23. Dezember 2020 02:00 ET
|
Amryt Pharma plc
Amryt Granted Orphan Drug Designation by the FDA for AP103 DUBLIN, Ireland, and Boston MA, December 23, 2020, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage biopharmaceutical company...
Amryt Receives Ministry of Health Reimbursement Approval for Lojuxta® (lomitapide) in Saudi Arabia
17. Dezember 2020 02:00 ET
|
Amryt Pharma plc
Amryt Receives Ministry of Health Reimbursement Approval for Lojuxta® (lomitapide) in Saudi Arabia DUBLIN, Ireland, and Boston MA, December 17, 2020, Amryt (Nasdaq: AMYT, AIM: AMYT), a global,...
Holding(s) in Company
11. Dezember 2020 05:00 ET
|
Amryt Pharma plc
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i 1a. Identity of the...
Holding(s) in Company
09. Dezember 2020 09:45 ET
|
Amryt Pharma plc
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i 1a. Identity of the...
Amryt Group Receives Marketing Authorisation Approval for Lojuxta® in Brazil
09. Dezember 2020 02:00 ET
|
Amryt Pharma plc
Amryt Group Receives Marketing Authorisation Approval for Lojuxta® in Brazil DUBLIN, Ireland, and Boston MA, December 09, 2020, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage...
Amryt Announces $40m Private Placement with Leading Biotech Investors
08. Dezember 2020 02:00 ET
|
Amryt Pharma plc
Amryt Announces $40m Private Placement with Leading Biotech Investors DUBLIN, Ireland, and Boston MA, December 8, 2020, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage...